Concepedia

Publication | Open Access

Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study

DOIFull Paper Access

22

Citations

42

References

2023

Year

Yoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, Taku Naiki, Takehiro Uemura, Keisuke Yokota, Daisuke Kawakita, Motoki Nakamura, Ryo Ogawa, Takaya Shimura,
Cancer Medicine

Abstract

An increased eosinophil before the two-course treatment may be a predictor of irAEs in various cancers treated with different ICIs.

References

YearCitations

Page 1